Criteria Developed for Idiopathic Inflammatory Myopathies

This article originally appeared here.
Share this content:
Criteria Developed for Idiopathic Inflammatory Myopathies
Criteria Developed for Idiopathic Inflammatory Myopathies

THURSDAY, Dec. 28, 2017 (HealthDay News) -- New classification criteria have been developed for idiopathic inflammatory myopathies (IIM), according to an article published in the December issue of Arthritis & Rheumatology.

Ingrid E. Lundberg, M.D., Ph.D., from Karolinska University Hospital in Stockholm, and colleagues developed and validated new classification criteria for adult and juvenile IIM. Using published criteria and expert opinion, candidate variables were assembled; data were included from 47 rheumatology, dermatology, neurology, and pediatric clinics.

The researchers derived new criteria from 976 IIM patients and 624 non-IIM patients with mimicking conditions. Each item was given a weighted score; the total score corresponded to the likelihood of having IIM. A probability cutoff of 55 percent, representing a score of 5.5 (6.7 with muscle biopsy) was defined as probable IIM and had the best sensitivity and specificity (87 and 82 percent, respectively, without biopsies and 93 and 88 percent, respectively, with biopsies); this was recommended as the minimum to classify a patient with IIM. Definite IIM was defined based on a probability of ≥90 percent, corresponding to a score of ≥7.5 (≥8.7 with muscle biopsy). A probability of <50 percent, representing a score of <5.3 (<6.5 with muscle biopsy), ruled out IIM.

"The European League Against Rheumatism/American College of Rheumatology classification criteria for IIM have been endorsed by international rheumatology, dermatology, neurology, and pediatric groups," the authors write.

One author disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

CDC: Birth Rate for 10- to-14-Year-Olds at Record Low in 2016

CDC: Birth Rate for 10- to-14-Year-Olds at Record ...

Reduction in birth rates for all race and Hispanic origin groups; largest decline in non-Hispanic blacks

Lonafarnib May Lower Mortality in Hutchinson-Gilford Progeria

Lonafarnib May Lower Mortality in Hutchinson-Gilford Progeria

Lower mortality seen with lonafarnib monotherapy after 2.2 years compared with no treatment

About 40 Percent of Men Report Experiencing Weight Stigma

About 40 Percent of Men Report Experiencing Weight ...

Experience of weight stigma associated with increased odds of underweight or obesity

is free, fast, and customized just for you!

Already a member?

Sign In Now »